Renalytix shares are trading lower after the company reported worse-than-expected FY23 revenue results and issued FY24 guidance.
Portfolio Pulse from Benzinga Newsdesk
Renalytix reported worse-than-expected FY23 revenue results and issued FY24 guidance, causing its shares to trade lower.
September 28, 2023 | 3:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Renalytix's worse-than-expected FY23 revenue results and FY24 guidance have led to a decrease in its share price.
Renalytix's shares are trading lower due to the company's worse-than-expected FY23 revenue results and the issuance of FY24 guidance. This news directly impacts the company's financial performance and investor sentiment, leading to a decrease in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100